Literature DB >> 4753874

Sensory nerve conduction in the upper limbs at various stages of diabetic neuropathy.

P Noël.   

Abstract

In 59 diabetic patients, sensory nerve potentials were recorded at various sites along the course of the median nerve. Pathological responses were characterized by reduced amplitude, desynchronization and decreased conduction velocity (CV). Four groups of patients with increasingly severe nerve dysfunction were distinguished. The presence and severity of clinical neuropathy in the upper limbs could be related to decreased maximal sensory nerve CV in the proximal segment of the limbs. When maximal sensory nerve CV was normal above the wrist, neuropathy usually remained latent. In severe cases where no sensory nerve potentials could be recorded, the cerebral evoked potentials nonetheless permitted a precise evaluation of the somatosensory conduction. In these cases, maximal sensory nerve CV was very low. In five patients with a so-called diabetic mononeuropathy, abnormal nerve potentials were recorded in the median nerve, although no clinical signs could be seen in the corresponding territory. It is proposed that the diabetic nature of a mononeuropathy can be assessed by the finding of latent abnormalities in seemingly normal nerve.

Entities:  

Mesh:

Year:  1973        PMID: 4753874      PMCID: PMC494457          DOI: 10.1136/jnnp.36.5.786

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

1.  Cerebral evoked potentials in patients with dissociated sensory loss.

Authors:  A M HALLIDAY; G S WAKEFIELD
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-06       Impact factor: 10.154

2.  Peripheral nerve conduction in diabetic neuropathy.

Authors:  R W GILLIATT; R G WILLISON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-02       Impact factor: 10.154

3.  The relative excitability and conduction velocity of sensory and motor nerve fibres in man.

Authors:  G D DAWSON
Journal:  J Physiol       Date:  1956-02-28       Impact factor: 5.182

4.  Motor nerve conduction velocity in diabetes.

Authors:  D G LAWRENCE; S LOCKE
Journal:  Arch Neurol       Date:  1961-11

5.  Sensory perception thresholds in patients with juvenile diabetes and their close relatives.

Authors:  R H Chochinov; G L Ullyot; J A Moorhouse
Journal:  N Engl J Med       Date:  1972-06-08       Impact factor: 91.245

6.  Determination of peripheral sensory nerve conduction velocities in man from stimulus response delays of the cortical evoked potentials.

Authors:  G J Ball; M G Saunders; J Schnabl
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1971-05

7.  [Cerebral evoked potentials in infantile hemiplegia].

Authors:  P Noël; J E Desmedt
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1972 Apr-Jun

8.  A patho-anatomical study of the central and peripheral nervous system in diabetes of early onset and long duration.

Authors:  Y Olsson; J Säve-Söderbergh; P Sourander; L Angervall
Journal:  Pathol Eur       Date:  1968

Review 9.  Disorders of the nervous system in diabetes.

Authors:  S G Eliasson
Journal:  Med Clin North Am       Date:  1971-07       Impact factor: 5.456

10.  Electrophysiological studies in diabetic neuropathy.

Authors:  A Lamontagne; F Buchthal
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

View more
  9 in total

1.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

2.  Peripheral motor nerve function in diabetic autonomic neuropathy.

Authors:  D J Ewing; A A Burt; I R Williams; I W Campbell; B F Clarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-05       Impact factor: 10.154

3.  Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice.

Authors:  N Takeshita; I Yamaguchi
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Peroneal motor nerve conduction velocity in diabetic children and adolescents. Relationships to metabolic control, HLA-DR antigens, retinopathy, and EEG.

Authors:  H Dorchy; P Noel; M Kruger; V de Maertelaer; E Dupont; D Toussaint; S Pelc
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

5.  Diabetic neuropathy in the upper limb and the effect of twelve months sorbinil treatment.

Authors:  R J Guy; S G Gilbey; M Sheehy; P Asselman; P J Watkins
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

6.  Evaluation of thermal and vibration sensation in diabetic neuropathy.

Authors:  R J Guy; C A Clark; P N Malcolm; P J Watkins
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

7.  Diagnosis of diabetic polyneuropathy. Correlation between clinical and instrumental findings and assessment of simple diagnostic criteria.

Authors:  E Beghi; M Treviso; P Ferri; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1988-12

8.  Subclinical nerve dysfunction in children and adolescents with IDDM.

Authors:  L Hyllienmark; T Brismar; J Ludvigsson
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

9.  Ganglioside treatment in diabetic peripheral neuropathy: a multicenter trial.

Authors:  G Crepaldi; D Fedele; A Tiengo; L Battistin; P Negrin; G Pozza; N Canal; G C Comi; G Lenti; G Pagano
Journal:  Acta Diabetol Lat       Date:  1983 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.